Sight Sciences, Inc.
SGHTNASDAQHealthcare● Active
$4.63
+$0.18(+4.04%)
Market Cap$251917837
P/E Ratio—
52W High$9.236
52W Low$3.11
Sight Sciences, Inc. (SGHT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SGHT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$0.16
Est. -$0.19 · +15.8%
Revenue
$0.02B
Est. $0.02B · +6.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 5-Quarter EPS Beat Streak
SGHT reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.15 | — | — | — | $0.02B | — |
| ▲ Q2 FY2026 | May 6, 2026 | -$0.19 | -$0.16 | +15.8% | $0.02B | $0.02B | +6.7% |
| ▲ Q1 FY2026 | Mar 4, 2026 | -$0.15 | -$0.08 | +46.7% | $0.02B | $0.02B | +0.2% |
| ▲ Q4 FY2025 | Nov 6, 2025 | -$0.26 | -$0.16 | +38.5% | $0.02B | $0.02B | -2.2% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.25 | -$0.23 | +8.0% | $0.02B | $0.02B | +10.3% |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.29 | -$0.28 | +3.5% | $0.02B | $0.02B | -5.3% |
| ▼ Q1 FY2025 | Mar 5, 2025 | -$0.22 | -$0.23 | -4.5% | $0.02B | $0.02B | +3.1% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.23 | -$0.22 | +4.3% | $0.02B | $0.02B | -0.6% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.15
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
-$0.16
EPS Est.
-$0.19
EPS Surpr.
+15.8%
Revenue
$0.02B
Q1 FY2026
Mar 4, 2026Beat
EPS Actual
-$0.08
EPS Est.
-$0.15
EPS Surpr.
+46.7%
Revenue
$0.02B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.26
EPS Surpr.
+38.5%
Revenue
$0.02B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.23
EPS Est.
-$0.25
EPS Surpr.
+8.0%
Revenue
$0.02B
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.28
EPS Est.
-$0.29
EPS Surpr.
+3.5%
Revenue
$0.02B
Q1 FY2025
Mar 5, 2025Miss
EPS Actual
-$0.23
EPS Est.
-$0.22
EPS Surpr.
-4.5%
Revenue
$0.02B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$0.22
EPS Est.
-$0.23
EPS Surpr.
+4.3%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2028 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2028 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q1 FY2028 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q4 FY2027 | $-0.11 | $-0.10 | $-0.10 | 1 |
| Q3 FY2027 | $-0.12 | $-0.12 | $-0.11 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +15.8% | $4.33 | $4.30 | -0.69% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +46.7% | $5.26 | $5.41 | +2.85% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +38.5% | $5.03 | $5.00 | -0.60% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +8.0% | $3.68 | $3.55 | -3.53% |
| ▲ Q2 FY2025 | May 8, 2025 | +3.5% | $2.86 | $3.03 | +5.94% |
| ▼ Q1 FY2025 | Mar 5, 2025 | -4.5% | $2.47 | $2.42 | -2.02% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +4.3% | $5.10 | $4.68 | -8.24% |
| ▲ Q3 FY2024 | Aug 1, 2024 | +19.4% | $7.78 | $7.42 | -4.63% |
Q2 FY2026-0.69%
Report Date
May 6, 2026
EPS Beat/Miss
+15.8%
Price Before
$4.33
Price After
$4.30
Q1 FY2026+2.85%
Report Date
Mar 4, 2026
EPS Beat/Miss
+46.7%
Price Before
$5.26
Price After
$5.41
Q4 FY2025-0.60%
Report Date
Nov 6, 2025
EPS Beat/Miss
+38.5%
Price Before
$5.03
Price After
$5.00
Q3 FY2025-3.53%
Report Date
Aug 7, 2025
EPS Beat/Miss
+8.0%
Price Before
$3.68
Price After
$3.55
Q2 FY2025+5.94%
Report Date
May 8, 2025
EPS Beat/Miss
+3.5%
Price Before
$2.86
Price After
$3.03
Q1 FY2025-2.02%
Report Date
Mar 5, 2025
EPS Beat/Miss
-4.5%
Price Before
$2.47
Price After
$2.42
Q4 FY2024-8.24%
Report Date
Nov 7, 2024
EPS Beat/Miss
+4.3%
Price Before
$5.10
Price After
$4.68
Q3 FY2024-4.63%
Report Date
Aug 1, 2024
EPS Beat/Miss
+19.4%
Price Before
$7.78
Price After
$7.42
Avg Beat Reaction-1.27%
Avg Miss Reaction-2.02%
Beat Rate7 / 8 quarters
Largest Move-8.24% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SGHT ends December
Sight Sciences, Inc. (SGHT) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-0.16 — beating the analyst consensus of $-0.19 by +15.8%. SGHT has beaten EPS estimates for 5 consecutive quarters. The next SGHT earnings date is expected around September 1, 2026.
Each quarter, investors track SGHT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SGHT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SGHT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SGHT earnings · 5 questionsSight Sciences, Inc.'s next earnings report is expected around September 1, 2026. SGHT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SGHT historically reports after market close (AMC).
SGHT earnings datewhen is SGHT earningsSGHT next earnings datewhen does SGHT report earningsSGHT earnings calendar
▸ Source: FMP · Sight Sciences, Inc. SEC filings · US GAAP · Sight Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026